article thumbnail

NIH spent $8.1B for phased clinical trials of drugs approved 2010-19, ~10% of reported industry spending

SCIENMAG: Medicine & Health

billion in project funding for phased clinical trials involving drugs approved by the FDA from 2010-2019, according to a new study from Bentley University’s Center for Integration of Science and Industry. BENTLEY UNIVERSITY Credit: Bentley University BENTLEY UNIVERSITY The U.S. National Institutes of Health (NIH) contributed $8.1

article thumbnail

Older Siblings Made Possible Just-Approved Gene Therapy for Metachromatic Leukodystrophy

PLOS: DNA Science

A Long and Winding Diagnostic Road The story begins in 2011, with Alessandra Biffi, MD, head of the clinical trial for MLD at the San Raffaele Telethon Institute for Gene Therapy in Milan. Two of their children, Liviana and Giovanni, participated in the clinical trial. Giovanni was born in January 2010. She passed away in 2013.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advancing reduction of drug use as an endpoint in addiction treatment trials

National Institute on Drug Abuse: Nora's Blog

Advancing reduction of drug use as an endpoint in addiction treatment trials astewart Thu, 03/06/2025 - 09:59 Nora's Blog March 18, 2025 Image Getty Images/ SolStock This blog was also published in the American Society of Addiction Medicine (ASAM) Weekly on March 18, 2025.&

article thumbnail

How 3D human tissue models are transforming drug discovery

Drug Target Review

Also, adoption of 3D human tissue models will help reduce the number of failed clinical trials because ineffective drugs are weeded out pre-clinically. Lastly, by using 3D human tissue models, patients in clinical trials will be exposed to fewer ineffective drugs, reducing their risk of side effects without any benefit.

Drugs 116
article thumbnail

CAR-NK cells: promising for cancer therapy

Drug Target Review

Up until 2023 around 600 NK cell clinical trials have been reported and some 200 are clinically active and still recruiting patients. The vast majority (65/74; 88%) of those trials involved NK cells without CARs; while only 12 percent were CAR-NK studies. CAR-NK cell trials only commenced in 2017 and most are still recruiting patients.

Therapies 118
article thumbnail

Before Clinical Trials: The Long Game of Rare Disease Research

Conversations in Drug Development Trends

Back in 2010, Rob Long was a 22-year-old football player at Syracuse University on the path towards his dream career of becoming a punter in the NFL. Over the next few decades, that drug made its way through clinical trials, securing approval in 2007—just 36 months before Rob was diagnosed in 2010. But what was truly remarkable?

article thumbnail

Deliberate Dysentery

Codon

Human challenge trials were an indispensable part of the development of the malaria vaccine, R21/Matrix-M, endorsed by the World Health Organization last October. But for all of their benefits, human challenge trials have their drawbacks. Jake himself has participated in both Zika and Shigella challenge trials.

Vaccine 126